Frazier Management LLC Aptinyx Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$2.27 - $3.62 $4.27 Million - $6.82 Million
-1,883,244 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$2.39 - $3.5 $3.12 Million - $4.57 Million
-1,306,835 Reduced 40.97%
1,883,244 $5.33 Million
Q2 2018

Aug 15, 2018
BUY
$19.83 - $24.17 $63.3 Million - $77.1 Million
3,190,079 New
3,190,079 $77.1 Million

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email